In this session, we explore the latest NICE 2023 guidance on lipids, statins, and cardiovascular risk, along with updates from the AAC. Key points include criteria for offering statins without risk calculation, the use of QRISK3 for risk assessment, and specific considerations for groups like those with chronic kidney disease, very elderly patients, and individuals with type 1 diabetes. We'll also cover practical aspects of communication, lifestyle advice, monitoring, and alternative treatments for statin intolerance. This video aims to make these guidelines practical and easy to follow for daily clinical use.

00:00 Introduction to Lipids, Statins, and Cardiovascular Risk

00:16 Who Should Be Offered Statins?

01:22 Special Considerations for Different Groups

02:09 Lifestyle and Statin Therapy

02:53 Monitoring and Treatment Goals

03:53 Alternatives to Statins

04:41 Managing Statin Side Effects

05:40 Conclusion and Key Takeaways